Fired from his position as Chair of the Board of Directors of Galvani Bioelectronics for sexual misconduct, Moncef Slaoui apologizes to his former colleague.

In a statement posted on PRNewswire, Moncef Slaoui said he was taking time off duty to focus on his family to whom he also apologized. “It is with deep regret that I acknowledge today’s statement from GlaxoSmithKline regarding my termination as Chair of the Galvani Board of Directors,” Slaoui said in a statement yesterday Wednesday, March 24th.

“I have the utmost respect for my colleagues and feel terrible that my actions have put a former colleague in an uncomfortable situation. I would like to apologise unreservedly to the employee concerned and I am deeply sorry for any distress caused”, he said.

This comes after the board of directors of GlaxoSmithKline plc (GSK) has previously announced the termination of Dr. Slaoui’s contract, with immediate effect.

The dismissal follows the receipt of a “letter containing allegations of sexual harassment and inappropriate conduct towards an employee of GSK by Dr. Slaoui, which occurred several years ago when he was an employee of GSK”, announced the group in a press release.

Upon receipt of the letter, GSK’s board immediately opened an investigation via an experienced law firm to investigate the allegations, the same source continues.

The investigation into Dr. Slaoui’s conduct has corroborated the allegations and is still ongoing, continues the group, which stresses that “Dr. Slaoui’s behaviors are wholly unacceptable”, adding that “sexual harassment is strictly prohibited and will not be tolerated”.

It is noted that Dr. Slaoui, who spent 30 years at GlaxoSmithKline (GSK), served as Chief Scientist for “Operation Warp Speed”, the US government’s project to develop vaccines against Covid-19.

The post Sexual Misconduct… Moncef Slaoui Apologizes to Former Colleague appeared first on Morocco Telegraph.